Physician profile
Daniel Joseph Cuttica
NPI 1659580298
$143,340.18
in general payments reported to CMS, 2019-2025
42 companies · $35K in 2025
The $35K reported for 2025 was more than what 88% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $6,585 · 2021: $6,172 · 2022: $32K · 2023: $21K · 2024: $31K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Travel and Lodging: $17K · Royalty Or License: $7,629 · Food and Beverage: $3,899 · Grant: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,568.75 |
| Travel and Lodging | $16,641.94 |
| Royalty Or License | $7,628.53 |
| Food and Beverage | $3,898.81 |
| Grant | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $63,319.80 | 2022-2025 | Ibs, Colink Plating System, Quantum |
| International Life Sciences | $32,432.98 | 2019-2024 | Flexband |
| Medartis INC. | $19,752.14 | 2022-2023 | Aptus |
| Treace Medical Concepts, INC. | $7,400.00 | 2019-2020 | |
| Stryker Corporation | $7,064.43 | 2021-2025 | Flexband, 1788, Mild Device Kit |
| In2bones USA, LLC | $5,437.36 | 2022 | |
| Supreme Orthopedic Systems, LLC | $4,248.88 | 2019-2025 | |
| Smith+Nephew, INC. | $553.88 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Stravix |
| Integra Lifesciences Corporation | $356.16 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $296.71 | 2021-2025 | Puraply, Simplimax, Affinity |
| Novastep INC. | $280.20 | 2022 | |
| Arthrex, INC. | $229.13 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $222.49 | 2019-2023 | Affixus |
| Medline Industries Lp | $200.58 | 2023-2024 | |
| Paragon 28, INC. | $190.80 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $168.10 | 2022 | |
| Horizon Therapeutics Plc | $125.01 | 2019-2022 | |
| Restor3d, INC. | $102.47 | 2023 | |
| Crossroads Extremity Systems, LLC | $98.57 | 2019 | |
| Nextremity Solutions INC. | $94.57 | 2020 | |
| Convatec INC. | $92.79 | 2024-2025 | |
| Theramicro, INC. | $92.15 | 2025 | Tekbrace Solo |
| Pacira Pharmaceuticals Incorporated | $71.25 | 2024-2025 | Exparel, Zilretta |
| Bioventus LLC | $55.19 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Acumed LLC | $48.49 | 2024 | Acumed, Osteomed |
| Amgen INC. | $47.49 | 2024-2025 | Krystexxa |
| Kerecis Limited | $38.46 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $34.84 | 2023 | Irrisept |
| One Surgical, INC. | $33.89 | 2019 | |
| Abbott Laboratories | $27.22 | 2019 | |
| Depuy Synthes Sales INC. | $25.18 | 2023 | Va-Lcp |
| Bone Support INC. | $24.32 | 2022 | |
| Ibsa Pharma INC. | $24.29 | 2023 | Tirosint, Licart |
| Progenacare Global, LLC | $22.69 | 2024 | |
| Fidia Pharma USA INC. | $22.53 | 2022 | |
| Heron Therapeutics, INC. | $20.77 | 2023 | Zynrelef |
| Tactile Systems Technology INC | $16.77 | 2019 | |
| Curonix LLC | $15.27 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cashflow Solutions, LLC | $15.21 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Medtronic, INC. | $13.28 | 2024 | Intellis Adaptivestim |
| Avanos Medical | $12.73 | 2019 | |
| Next Science LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cuttica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.